Overview

A Study of Two Different Test Formulations Compared to the Reference Formulation of Macitentan in Healthy Adult Participants

Status:
Not yet recruiting

Trial end date:
2022-08-21

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the rate and extent of absorption of a single oral dose of macitentan given as 2 test formulations compared to the reference formulation under fed conditions in healthy adult participants.

Phase:

Phase 1

Details

Lead Sponsor:

Actelion

Treatments:

Macitentan